Objective The role of metabolic syndrome (MS) and its individual components in
postmenopausal breast cancer (PBC) risk is still unclear. We reviewed and summarized …

Background. Although individual metabolic risk factors are reported to be associated with
breast cancer risk, controversy surrounds risk of breast cancer from metabolic syndrome …

Background: Association between metabolic syndrome (MetS) and incidence of breast
cancer remains to be validated. Moreover, whether menopausal status of the women affects …

Background Only a few small studies investigated the association between postmenopausal
breast cancer and metabolic syndrome (MetS) as a single entity. Materials and methods We …

Background Metabolic syndrome (defined as at least three among abdominal obesity, high
blood triglycerides, low high-density lipoprotein cholesterol, high blood glucose, and high …

Abstract Background Metabolic syndrome (MetS) has been suggested to be a risk factor for
many cancers, including breast cancer. However, it remains unclear whether MetS predicts …

Abstract Background: The metabolic syndrome (MetS) has been associated with the
pathogenesis and prognosis of various malignant tumors. In this systematic review and meta …

Postmenopausal women show the highest incidence of breast cancer in the female
population and are often affected by metabolic syndrome. Metabolic syndrome (MS) …

Objective The aim of this study was to assess the risk of metabolic syndrome (MetS) in
postmenopausal breast cancer survivors as compared with postmenopausal women without …

The metabolic syndrome, characterized by abdominal obesity, high blood glucose levels,
impaired glucose tolerance, dyslipidemia, and hypertension, is associated with increased …